组织多肽抗原(TPA)与癌胚抗原(CEA)相比,似乎是一种更好的肿瘤标志物。这是根据若干研究后得出的结沦,主要是欧洲的研究。1982年6月在慕尼黑召开的第一次国际人类肿瘤标志物会议上科学家们作了有关的报告。17个国家的90位生物学家和临床学家根据肿瘤标志物的生物学基础及其临床方面,在会上介绍了他们的研究情况。斯德哥尔摩的国家细菌学实验室所属肿瘤免疫学系的B Bjorklund报告你,TPA是一种抗原分子,通常存在于人类癌瘤中。增生的肿瘤细胞或正常细胞均可产生和释放TPA。 Tissue polypeptide antigen (TPA) appears to be a better tumor marker than carcinoembryonic antigen (CEA). This is based on the findings of several studies, mainly European studies. Scientists made relevant reports at the first international conference on human tumor markers held in Munich in June 1982. Ninety biologists and clinicians in 17 countries presented their research on the basis of the biological basis of tumor markers and their clinical aspects. B Bjorklund, of the Department of Tumor Immunology at the National Bacteriological Laboratory in Stockholm, reports that TPA is an antigen molecule that is usually found in human cancers. Both proliferating tumor cells and normal cells can produce and release TPA.